Intra-amniotic LPS causes acute neuroinflammation in preterm rhesus macaques by Augusto F. Schmidt et al.
RESEARCH Open Access
Intra-amniotic LPS causes acute
neuroinflammation in preterm rhesus
macaques
Augusto F. Schmidt1, Paranthaman S. Kannan1, Claire A. Chougnet2, Steve C. Danzer3, Lisa A. Miller4,
Alan H. Jobe1 and Suhas G. Kallapur1*
Abstract
Background: Chorioamnionitis is associated with an increased risk of brain injury in preterm neonates.
Inflammatory changes in brain could underlie this injury. Here, we evaluated whether neuroinflammation
is induced by chorioamnionitis in a clinically relevant model.
Methods: Rhesus macaque fetuses were exposed to either intra-amniotic (IA) saline, or IA lipopolysaccharide (LPS)
(1 mg) 16 or 48 h prior to delivery at 130 days (85 % of gestation) (n = 4–5 animals/group). We measured cytokines in
the cerebrospinal fluid (CSF), froze samples from the left brain for molecular analysis, and immersion fixed the right
brain hemisphere for immunohistology. We analyzed the messenger RNA (mRNA) levels of the pro-inflammatory
cytokines IL-1β, CCL2, TNF-α, IL-6, IL-8, IL-10, and COX-2 in the periventricular white matter (PVWM), cortex, thalamus,
hippocampus, and cerebellum by RT-qPCR. Brain injury was assessed by immunohistology for myelin basic protein
(MBP), IBA1 (microglial marker), GFAP (astrocyte marker), OLIG2 (oligodendrocyte marker), NeuN (neuronal marker), CD3
(T cells), and CD14 (monocytes). Microglial proliferation was assessed by co-immunostaining for IBA1 and Ki67. Data
were analyzed by ANOVA with Tukey’s post-test.
Results: IA LPS increased mRNA expression of pro-inflammatory cytokines in the PVWM, thalamus, and cerebellum,
increased IL-6 concentration in the CSF, and increased apoptosis in the periventricular area after 16 h. Microglial
proliferation in the white matter was increased 48 h after IA LPS.
Conclusions: LPS-induced chorioamnionitis caused neuroinflammation, microglial proliferation, and periventricular
apoptosis in a clinically relevant model of chorioamnionitis in fetal rhesus macaques. These findings identify specific
responses in the fetal brain and support the hypothesis that neuroinflammatory changes may mediate the adverse
neurodevelopmental outcomes associated with chorioamnionitis.
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Background
Chorioamnionitis is frequently associated with pre-
term birth [1], and fetal exposure to inflammation is
an independent risk factor for brain injury, including
intraventricular hemorrhage (IVH), periventricular
leukomalacia (PVL), cerebral palsy (CP), and cognitive
impairment [2, 3]. In a multicenter prospective study
of 3094 infants born before 33 weeks’ gestational age,
clinical chorioamnionitis increased the risk of severe
intraventricular hemorrhage, with an odds ratio of
1.62 [4]. Histological chorioamnionitis increased the
risk of intraventricular hemorrhage, periventricular
leukomalacia, and cerebral palsy on neurodevelop-
mental testing between 30 and 42 months corrected
age (odds ratio 2.45) in a recent retrospective study
with prospective follow-up including infants born
with less than 29 weeks gestational age [5].
Selection of the animal model is a critical variable for
research examining chorioamnionitis-induced brain in-
jury. The most commonly used model for inflammation
induced brain injury combines hypoxia/ischemia and in-
traperitoneal lipopolysaccharide (LPS) in term newborn
rodents [6]. Neuroinflammation, characterized by micro-
glial activation and damage to the white matter, is con-
sistently observed in this model [7]. Additionally,
preterm infants with exposure to histological chorioam-
nionitis have only modest increases in inflammatory
cytokines in the serum and do not have manifestations
of systemic inflammatory response [8].
Systemic inflammation can cause an inflammatory
response in the fetal brain with microglial activation, up-
regulation of cytokines, and neuronal apoptosis [9, 10].
In neonatal rats, intra-cerebral injection of IL-1β induces
apoptosis and astrogliosis and decreases myelin basic
protein (MBP) staining [11]. The IL-1β injection results
in long-term neuro-inflammatory responses and
motor behavioral deficits, which are attenuated by an
IL-1 receptor antagonist [12]. Another cytokine that
has been implicated in the pathogenesis of brain in-
jury in preterm infants is IL-6. Increased IL-6 con-
centrations in the cord blood of preterm newborns
are associated with increased risk of white matter
damage, germinal matrix hemorrhage, and cystic
lesions [13, 14]. Brain injury secondary to diverse in-
sults such as trauma, excitatory injury, and infection
is also associated with increased expression of COX-2,
but there are no data regarding its role in brain in-
jury associated with chorioamnionitis [15].
Inflammation in human chorioamnionitis is largely
localized to the uterus, without overt fetal hypoxia or
strong maternal systemic inflammatory responses. In
fact, measurements of systemic inflammatory markers
such as procalcitonin, CRP and IL-6 in the maternal
serum do not identify intrauterine inflammation [16, 17].
In contrast to intraperitoneal or systemic LPS injections,
intra-amniotic (IA) injections of pro-inflammatory medi-
ators such as IL-1β or LPS induce a predominantly chor-
ioamniotic inflammation with subtle fetal systemic
inflammation, similar to the pathology in humans [18].
In preterm fetal sheep, IL-1β was upregulated in the
hippocampus, cortex, and cerebellum 2 days after expos-
ure to IA LPS [19], followed by microglial and astrocyte
recruitment, apoptosis, and decreased myelination of the
subcortical white matter and hippocampus after 7 days
[20]. Nonetheless, although studies in rodents and sheep
provide some insight into the human pathology, there
are striking differences in neurological development and
vulnerability to brain injury between these species and
humans.
In humans, generation of oligodendrocytes peaks be-
tween 23 and 32 weeks of gestation, while in rodents,
peak oligodendrogenesis is delayed until 1 to 3 days after
birth. Similarly, peak brain growth and gliogenesis occur
between 36 and 40 weeks’ gestation in humans, whereas
in rodents, the peak occurs between postnatal days 7 to
10 [21]. In contrast to rodents, where development is
delayed relative to humans, sheep develop at a faster rate
than humans. In sheep, 50 % of the adult brain weight is
achieved at 80 % of gestation, while humans do not
reach this milestone until early infancy. Similarly, the in-
ternal capsule myelination starts at 70 % of gestation in
sheep and not until 40 days postnatally in humans [22].
In contrast, rhesus macaques reach 50 % of adult brain
weight at term and peak internal capsule myelination
starts at 90 % gestation, closer to human development.
Thus, nonhuman primate models, such as rhesus ma-
caques, are especially attractive due to similar ontogeny
of the nervous systems [22].
We tested the hypothesis that IA administration of
LPS will induce inflammation in the central nervous sys-
tem in the rhesus macaque.
Methods
Animals
The Institutional Animal Care and Use Committee at
the University of California Davis approved all animal
procedures, which were performed at the California Na-
tional Primate Research Center (CNPRC), University of
California, Davis. Time-mated pregnant rhesus ma-
caques were sedated with ketamine at approximately day
130 of gestation (term is 165 days) for ultrasound exam
and IA injection of either LPS (1 mg, E. coli O55:B5,
Sigma Aldrich, Saint Louis, MO) diluted in 1 mL of ster-
ile saline solution or 1 mL of sterile saline as the control
injection. After 16 or 48 h, fetuses were surgically deliv-
ered for fetal tissue collection. We collected cerebro-
spinal fluid (CSF) by occipital puncture. The left brain
was dissected and the cortex, periventricular white
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matter (PVWM), thalamus, hippocampus, and cerebel-
lum were snap frozen for molecular analysis. The right
brain was fixed in 10 % formalin. We used four to five
animals for each group.
mRNA quantitation
Total RNA was isolated from frozen brains after
homogenization with TRIzol (Invitrogen, Carlsbad, CA)
and column purified with RNeasy Universal MiniKit
(Qiagen, Valencia, CA) according to the manufacturer’s
instructions. Reverse transcription was performed using
Verso complementary DNA (cDNA) kit (Thermo Scien-
tific, Waltham, MA) to produce single-strand cDNA.
The genes for IL-1β, CCL2, TNF-α, IL-6, IL-8, IL-10,
cyclooxygenase-2 (COX-2), and prostaglandin E synthase
2 (PTGES2) were amplified by RT-PCR using the cDNA
template and rhesus macaque-specific primers along
with Taqman probes (Applied Biosystems, Foster City,
CA). The messenger RNA (mRNA) expression for each
gene was normalized to the mRNA for the ribosomal
protein 18 s as internal standard. Data are expressed as
fold increase over the mean control value.
Cytokine measurements
We measured cytokine concentrations in the CSF by Lumi-
nex using nonhuman primate multiplex kits (Millipore,
Billerica, MA) according to the manufacturer’s protocol.
Concentrations were calculated from standard curves using
recombinant proteins and expressed in picograms per
milliliter.
Immunohistochemistry
Sections from formalin fixed tissues in paraffin blocks
were deparaffinized and rehydrated before microwave-
assisted antigen retrieval in citric acid buffer at pH 6.0.
Endogenous peroxidase activity was reduced with
CH3OH/H2O2 treatment, and the tissue was blocked
with 2 % donkey serum in phosphate buffer saline (PBS).
Sections were incubated overnight at 4 °C with the pri-
mary antibody diluted in 2 % serum in PBS. We used
the following primary antibodies: goat polyclonal Anti-
Iba1 (Abcam, Cambridge, MA, cat. #5076, dilution
1:200), rabbit monoclonal Anti-glial fibrillary acidic pro-
tein (GFAP) (Abcam, Cambridge, MA, cat. #48050, dilu-
tion 1:500), rabbitt monoclonal Anti-Olig2 (Abcam,
Cambridge, MA, cat. #109186, dilution 1:500), mouse
monoclonal Anti-MBP (Abcam, Cambridge, MA, cat.
#62631, dilution 1:500), rabbit monoclonal Anti-Tau
(Abcam, Cambridge, MA, cat. #32057, dilution 1:500),
mouse monoclonal anti-NeuN (Abcam, Cambridge, MA,
cat. #ab104224, dilution 1:200), rabbit polyclonal anti-
CD3 (DakoCytomation, Carpinteria, CA, cat. #A0452,
dilution 1:100), and mouse monoclonal anti-CD14 (BD
Biosciences, San Diego, CA, cat. #557742, dilution
1:100). Sections were then washed and incubated with
the appropriate species-specific secondary antibody di-
luted 1:200 in 2 % serum for 2 h at room temperature.
After further washing, antigen/antibody complexes were
visualized using a Vectastain ABC peroxidase kit (Vector
Laboratories Inc., Burlingame, CA). Antigen detection
was enhanced with nickel-diaminobenzidine, followed by
incubation with Tris-cobalt. Slides were counterstained
with Nuclear Fast Red for photomicroscopy.
Double-labeling immunofluorescence
To identify proliferating microglia, we performed double-
labeling immunofluorescence for Iba-1 and Ki-67. Antigen
retrieval and blocking were conducted as described above,
followed by overnight incubation with goat polyclonal
Anti-Iba1 (Abcam, Cambridge, MA, cat. #5076, dilution
1:100) and rat monoclonal anti-Ki67 (LifeSpan Biosciences,
Seattle, WA, cat. #LS-C175347, dilution 1:50). The follow-
ing day, sections were washed and incubated with anti-
goat Alexa Fluor 594 (Life technologies, Carlsbad, CA, cat.
#A-11058, dilution 1:200) and anti-rat Alexa Fluor 488
(Life technologies, Carlsbad, CA, cat. #A-21470, dilution
1:200) for 2 h at room temperature, followed by washing
and incubation with DAPI (Life technologies, Carlsbad,
CA, cat. #D1306, dilution 1:2000) for 15 min at room
temperature. Sections were washed and mounted with Pro-
Long Gold (Life technologies, Carlsbad, CA, cat. #P36930).
Stained slides were imaged on confocal microscopy for co-
localization at ×40x magnification with 1024 × 1024 pixel
resolution on a Nikon Eclipse A1RSi inverted microscope
(Nikon Instruments Inc, Melville, NY).
Cell counting
Cells immunostained for CD3 (T cells), CD14 (mono-
cytes), and caspase-3 (apoptotic cells) were counted in
six randomly selected fields per animal on photomicro-
graphs (×40) from the periventricular area and counted
by a masked investigator. A similar strategy was used to
assess the number (Iba1+) and proportion of proliferat-
ing microglia (Ki67+/Iba1+) in the white matter. A
masked investigator counted the number of cells positive
for Iba1, and the number of cells positive for both Iba1
and Ki67 in each determined both the number of Iba1+
cells and the percentage of Iba1+/Ki67+ cells.
Statistical analysis
Results of the mRNA quantitation and cell counting
were analyzed by ANOVA followed by post-testing com-
parison of each experimental group against the control
group with Tukey correction. Statistical analysis was per-
formed on GraphPad Prism version 6.0 for Mac OS X
(GraphPad Software, San Diego, CA). Data are presented
as means ± standard deviation. Values of p < 0.05 were
considered significant.
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Results
Animals
Gestational ages at birth and birth weights were similar
among the animals (Table 1). One animal in the LPS
48 h group was a fetal death and was excluded from the
study. There was a non-significant trend towards in-
creased cord white blood cell and neutrophil counts
after IA LPS. The percentage of band form of neutro-
phils significantly increased in the LPS 16 h group com-
pared to control (p < 0.05).
IA LPS increases cytokine expression in the brain
In the PVWM, IL-1β mRNA increased by twofold 16
and 48 h after IA LPS (p < 0.05) (Fig. 1). In the cere-
bellum, IL-1β and COX-2 mRNA expression in-
creased 16 h after IA LPS (p < 0.05). In the thalamus,
expression of CCL2 and COX-2 mRNA increased in
the LPS 16 h group (p < 0.05). There were no changes
in expression of IL-6, IL-10, or PTGES2 in the
PVWM, cerebellum, or thalamus (Additional file 1).
IL-8 mRNA expression increased in the hippocampus
16 h after IA LPS, but no other cytokines were in-
creased. Cytokine mRNA levels were unchanged in
the cortex (Additional file 2).
IA LPS increases concentration of IL-6 concentration in
the plasma and CSF
IL-6 significantly increased in both the plasma and
CSF after IA LPS exposure. In plasma, a 300-fold in-
crease over controls was observed, while a more
modest 4-fold increase was evident in the CSF (Fig. 2).
The concentration of CCL2 was also increased in the
fetal plasma at 16 h but not in the CSF 16 h after IA
LPS exposure (Fig. 2). There were no differences in
the levels of other cytokines including IL-1β, IL-8, IL-
10, and TNF-α in the CSF or in the fetal plasma
(Additional file 3).
Table 1 Animal data
n Gestational age (days) Birth weight (grams) Sex (M/F) WBC (109/L)* Neutrophils (%) Bands (%)
Control 5 132 ± 2 343 ± 9 3/2 2.0 ± 0.9 9 ± 3 0
LPS 16 h 5 131 ± 1 333 ± 43 2/3 2.0 ± 0.4 14 ± 15 1.5 ± 1*
LPS 48 h 4 130 ± 2 307 ± 17 0/4 3.3 ± 1.7 25 ± 10 1 ± 1
WBC white blood cell count
*p < 0.05
Fig. 1 mRNA quantitation of pro-inflammatory cytokines by RT-PCR in the brain. Total mRNA was extracted from snap frozen areas of the brain.
mRNA quantitation was performed by RT-PCR using rhesus specific Taqman probes. The mRNA levels are expressed as fold change relative to
control after internal normalization to 18s RNA. Exposure to intra-amniotic (IA) LPS increases the expression of IL-1β in the PVWM and thalamus,
COX-2 in the cerebellum and thalamus, and CCL2 in the thalamus. *p < 0.05 vs control
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IA LPS induces apoptosis in the white matter
We performed immunohistochemistry for activated
caspase 3 in order to identify cells undergoing apop-
tosis. Caspase 3 positive cells were significantly in-
creased in the periventricular white matter 16 h after
IA LPS (p < 0.05), which lowered at 48 h after IA LPS
(Fig. 3). There were no differences in the intensity or
pattern of immunostaining for Iba-1, GFAP, MBP,
Olig2, Tau, and NeuN (Fig. 4). We did not observe
infiltrating leukocytes (CD3+) or infiltrating mono-
cytes (CD14+) in the brain after IA LPS (Fig. 5).
IA LPS induces proliferation of microglia
In order to identify and count the proportion of prolifer-
ating microglia in the white matter, we performed
double-labeling immunofluorescence for Iba-1 and Ki-
67. We observed an increased percentage of proliferating
microglia 48 h after exposure to IA LPS (p < 0.05, Fig. 6).
Fig. 2 IL-6 concentration in the fetal plasma and CSF measured by ELISA. Exposure to IA LPS significantly increased the concentration of IL-6 in
the plasma and CSF. *p < 0.05 vs control
Fig. 3 Immunohistochemical staining for activated caspase-3 in the ventricular zone. Representative sections of paraffin-embedded brain tissue
from rhesus macaques fetus. Immunohistochemical staining for activated caspase-3 in the ventricular zone (arrows). Exposure to IA LPS increases
the number of activated caspase-3 positive cells in the ventricular zone 16 h after IA LPS. Representative micrographs show the immunostaining
pattern for activated caspase-3 for control, LPS 16 h, and LPS 48 h (×40). LV lateral ventricle. *p < 0.05 vs control
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Discussion
Prematurity is the most common cause of infant mortal-
ity in the USA [23] and is frequently associated with
chorioamnionitis, with at least 40 % of preterm births
having prenatal inflammation [24]. Moreover, chorioam-
nionitis is an independent risk factor for brain injury in
the neonatal period including IVH and PVL and late
neurodevelopmental impairment such as CP and cogni-
tive deficits [25–28]. Even in the absence of prematurity
or signs of early neonatal brain injury such as IVH and
PVL, chorioamnionitis is still associated with increased
risk of CP [29]. We report the novel finding of neuro-
inflammatory responses in a nonhuman primate model
of chorioamnionitis induced by IA LPS. Our data sug-
gest that neuroinflammation is a likely consequence of
the fetal inflammatory response syndrome.
Even though the association between systemic inflam-
mation and brain injury is well known, the specific
mechanisms through which circulating cytokines lead to
microglial activation and increased expression of
Fig. 4 Immunostaining for cellular markers in the brain. Immunostaining for microglia (Iba-1, ×20), astrocytes (GFAP, ×10), myelin basic protein
(MBP, ×10), oligodendrocytes (Olig2, ×10), axons (tau, ×10), and neurons (NeuN, ×10) was performed in coronal brain sections including for
analysis of the staining pattern focused in the motor cortex, periventricular white matter, thalamus, and hippocampus. No differences were
observed in staining pattern or intensity after exposure to IA LPS. Scale bars represent 200 μm
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cytokines in the central nervous system remain elusive
[30]. We measured increased levels of IL-6 in the plasma
and CSF of animals exposed to IA LPS. Increased IL-6
levels in cord blood and in the amniotic fluid have been
correlated with intrauterine infection/inflammation and
fetal inflammatory response syndrome [14, 31, 32]. Our
data showing a significant gradient between plasma and
CSF IL-6 is consistent with IL-6 crossing the blood-
brain barrier through a saturable transport system [33].
Even though the plasma concentration of CCL2 was in-
creased in LPS exposed animals, there was no significant
increase in the CSF concentration of this cytokine.
The increased circulating IL-6 may cross the blood-
brain barrier to the CSF. IL-6 in the central nervous sys-
tem has the potential to activate the resident microglia
and trigger a local inflammatory response with
upregulation of pro-inflammatory cytokines. In one
study of 146 preterm infants, the presence of higher CSF
concentrations of IL-6, IL-10, and TNF-α was associated
with white matter injury identified by magnetic reson-
ance imaging (MRI) at term equivalent age [13]. How-
ever, there was no relationship between CSF cytokines
and plasma cytokine concentrations. Elevated plasma
CCL2 can also mediate the neuro-inflammatory re-
sponse. CCL2, and its receptor have been implicated
in the pathogenesis of brain injury due to trauma and
autoimmune processes [34, 35]. Interestingly, the
CCL2 levels in the CSF may be reduced in auto-
immune conditions due to consumption by CCR2+
leukocytes [36]. After IA LPS, CCL2 concentration
did not increase in the fetal CSF and there was no in-
filtration of leukocytes.
Fig. 5 Cell count of CD14 and CD3 positive cells by immunostaining. Immunostaining was performed for CD14 and CD3 in order to investigate
the presence of immune cells in the brain after IA LPS. Positive cells were counted in eight random fields per slide in one slide per animal.
Numbers are reported as average total number of cells per slide. No differences were observed after exposure to IA LPS
Fig. 6 Double-labeling immunofluorescence for Iba-1 and Ki-67 and percentage of microglia labeling for Ki-67. Representative sections of
paraffin-embedded brain tissue from rhesus macaques fetus. Confocal microscopy showing a microglia labeled for nuclei (blue), Iba-1 (red), and
Ki-67 (green) (×60). Relative number of proliferating microglia: percentage of Iba-1positive cells that were co-stained for Ki-67. *p < 0.05 vs control
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The elevation of IL-1β in the PVWM at 16 and 48 h
after IA LPS may be especially important in the pathogen-
esis of white matter injury associated with chorioamnioni-
tis. In preterm infants, injury to pre-myelination
oligodendrocytes is central to the pathogenesis of white
matter injury [11]. The expression of IL-1β and COX-2
mRNA was increased in the cerebellum 16 h after IA LPS.
Although the cerebellum is not classically considered a
site of brain injury in premature infants, more recent find-
ings indicate that cerebellar underdevelopment may be
common in preterm infants [37]. A strong relationship
between decreased cerebellar volumes with presence of
PVL has been reported [38], suggesting a common insult,
such as inflammation, which is known to cause injury to
the developing cerebellum [39, 40]. Another site with
upregulation of pro-inflammatory cytokines after IA LPS
was the thalamus, where we observed a twofold increase
in CCL2 and COX-2 mRNA and a trend towards in-
creased IL-1β mRNA. Neuropathological studies of pre-
mature infants show greater neuronal loss in the thalamus
compared to the cortex and a higher incidence of thalamic
injuries in the presence of PVL [41, 42]. Due to its projec-
tions to the cerebral cortex and the role of the thalamus
in cognitive and social function, thalamic damage in PVL
could contribute to the encephalopathy of prematurity.
COX-2 has been investigated in neonatal brain following
hypoxic ischemic insults [43], but there are no data regard-
ing a potential role of this enzyme and prostaglandins in
the pathogenesis of encephalopathy of prematurity. The in-
ducible form of COX-2 is polymorphic and the allele asso-
ciated with decreased gene expression and decreased
synthesis of prostaglandin is independently associated with
worse long-term cognitive outcomes in preterm infants
[44]. The use of the nonspecific cyclooxygenase inhibitor
indomethacin in preterm newborns was associated with
decreased incidence of PVL, even though indomethacin
does not change long-term neurodevelopmental outcomes
[45]. We found increased expression of COX-2 mRNA in
the thalamus and cerebellum 16 h after exposure to IA
LPS, suggesting that COX-2 may also be implicated in the
brain injury induced by prenatal inflammation.
We also detected microglial proliferation after fetal ex-
posure to IA LPS that starts at 16 h and is significant
48 h after the initial insult. Microglia are important dur-
ing brain development with a variety of roles including
but not limited to neuronal proliferation and differenti-
ation, synaptic remodeling, and myelination [46]. Micro-
glia also have a central role in the inflammatory
response in the central nervous system, and PVL is asso-
ciated with marked microgliosis [47]. Once activated,
microglia release cytokines that can injure pre-
oligodendrocyte populations [48]. It is interesting that
the largest increase in microglial proliferation was after
48 h of IA LPS exposure, while cytokine mRNAs were
increased at 16 h. The continued microglial proliferation
could result in long-term consequences to the develop-
ment of brain as has been observed in rodents models,
where a single dose of intra-cerebral LPS leads to motor
behavioral changes through adulthood [11].
IA LPS increased apoptosis in the periventricular
white matter, as demonstrated by immunostaining for
activated caspase-3. This area is a frequent site of injury
in preterm infants [3]. Our findings are consistent with
other models of preterm and neonatal brain injury. In
rodents, intra-cerebral LPS induces apoptosis in the
white matter [49]. In the sheep model, IA LPS increases
the number of apoptotic cells in the PVWM and cortical
area, with associated microglial activation [20, 50]. In
this model, longer exposure to IA LPS resulted in in-
creased injury and abnormalities on EEG with increased
delta wave frequency after 14 days [50]. The association
of IA LPS, early expression of inflammatory markers in
the brain, and late functional changes supports the idea
that exposure to prenatal inflammation causes specific
inflammatory responses in the brain and may result in
the adverse neurodevelopmental outcomes observed in
preterm newborns exposed to chorioamnionitis.
Conclusions
IA injection of LPS in a nonhuman primate results in
modest acute inflammatory responses in the central ner-
vous system evidenced by increased cytokine in the CSF
and cytokine mRNA levels and microglial proliferation
in the brain. The inflammatory response is associated
with apoptosis in the periventricular white matter. This
novel model of fetal brain injury induced by chorioam-
nionitic inflammation should be useful for understand-
ing the pathogenesis of white matter injury associated
with prenatal inflammation. Our results suggest that the
brain injury in fetuses exposed to chorioamnionitis could
be mediated by circulating IL-6 and/or CCL2.
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